GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
112 hedge funds and large institutions have $793M invested in Genomic Health, Inc. in 2014 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 31 increasing their positions, 38 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
18% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 38
81% less call options, than puts
Call options by funds: $300K | Put options by funds: $1.59M
Holders
112
Holding in Top 10
2
Calls
$300K
Puts
$1.59M
Top Buyers
| 1 | +$26.7M | |
| 2 | +$5.92M | |
| 3 | +$5.53M | |
| 4 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$5.48M |
| 5 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
+$2.73M |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$5.89M | |
| 3 | -$3.12M | |
| 4 |
Renaissance Technologies
New York
|
-$2.86M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.58M |